183 related articles for article (PubMed ID: 12592324)
41. The role of the linker between the SH2 domain and catalytic domain in the regulation and function of Src.
Gonfloni S; Williams JC; Hattula K; Weijland A; Wierenga RK; Superti-Furga G
EMBO J; 1997 Dec; 16(24):7261-71. PubMed ID: 9405355
[TBL] [Abstract][Full Text] [Related]
42. Mutagenic analysis of the roles of SH2 and SH3 domains in regulation of the Abl tyrosine kinase.
Mayer BJ; Baltimore D
Mol Cell Biol; 1994 May; 14(5):2883-94. PubMed ID: 8164650
[TBL] [Abstract][Full Text] [Related]
43. Intramolecular interactions of the regulatory domains of the Bcr-Abl kinase reveal a novel control mechanism.
Nam HJ; Haser WG; Roberts TM; Frederick CA
Structure; 1996 Sep; 4(9):1105-14. PubMed ID: 8805596
[TBL] [Abstract][Full Text] [Related]
44. Polyomavirus middle-T antigen associates with the kinase domain of Src-related tyrosine kinases.
Dunant NM; Senften M; Ballmer-Hofer K
J Virol; 1996 Mar; 70(3):1323-30. PubMed ID: 8627648
[TBL] [Abstract][Full Text] [Related]
45. SH2-kinase linker mutations release Hck tyrosine kinase and transforming activities in Rat-2 fibroblasts.
Briggs SD; Smithgall TE
J Biol Chem; 1999 Sep; 274(37):26579-83. PubMed ID: 10473622
[TBL] [Abstract][Full Text] [Related]
46. Binding of src-like kinases to the beta-subunit of the interleukin-3 receptor.
Burton EA; Hunter S; Wu SC; Anderson SM
J Biol Chem; 1997 Jun; 272(26):16189-95. PubMed ID: 9195918
[TBL] [Abstract][Full Text] [Related]
47. Identification of novel SH3 domain ligands for the Src family kinase Hck. Wiskott-Aldrich syndrome protein (WASP), WASP-interacting protein (WIP), and ELMO1.
Scott MP; Zappacosta F; Kim EY; Annan RS; Miller WT
J Biol Chem; 2002 Aug; 277(31):28238-46. PubMed ID: 12029088
[TBL] [Abstract][Full Text] [Related]
48. Dynamic coupling between the SH2 and SH3 domains of c-Src and Hck underlies their inactivation by C-terminal tyrosine phosphorylation.
Young MA; Gonfloni S; Superti-Furga G; Roux B; Kuriyan J
Cell; 2001 Apr; 105(1):115-26. PubMed ID: 11301007
[TBL] [Abstract][Full Text] [Related]
49. SH3-mediated Hck tyrosine kinase activation and fibroblast transformation by the Nef protein of HIV-1.
Briggs SD; Sharkey M; Stevenson M; Smithgall TE
J Biol Chem; 1997 Jul; 272(29):17899-902. PubMed ID: 9218412
[TBL] [Abstract][Full Text] [Related]
50. Hck SH3 domain-dependent abrogation of Nef-induced class 1 MHC down-regulation.
Chang AH; O'Shaughnessy MV; Jirik FR
Eur J Immunol; 2001 Aug; 31(8):2382-7. PubMed ID: 11500821
[TBL] [Abstract][Full Text] [Related]
51. Reciprocal regulation of Hck activity by phosphorylation of Tyr(527) and Tyr(416). Effect of introducing a high affinity intramolecular SH2 ligand.
Porter M; Schindler T; Kuriyan J; Miller WT
J Biol Chem; 2000 Jan; 275(4):2721-6. PubMed ID: 10644735
[TBL] [Abstract][Full Text] [Related]
52. Induction of cytochrome c release and apoptosis by Hck-SH3 domain-mediated signalling requires caspase-3.
Radha V; Sudhakar Ch; Ray P; Swarup G
Apoptosis; 2002 Jun; 7(3):195-207. PubMed ID: 11997663
[TBL] [Abstract][Full Text] [Related]
53. Enhanced SH3/linker interaction overcomes Abl kinase activation by gatekeeper and myristic acid binding pocket mutations and increases sensitivity to small molecule inhibitors.
Panjarian S; Iacob RE; Chen S; Wales TE; Engen JR; Smithgall TE
J Biol Chem; 2013 Mar; 288(9):6116-29. PubMed ID: 23303187
[TBL] [Abstract][Full Text] [Related]
54. Physical and functional interaction between Hck tyrosine kinase and guanine nucleotide exchange factor C3G results in apoptosis, which is independent of C3G catalytic domain.
Shivakrupa R; Radha V; Sudhakar Ch; Swarup G
J Biol Chem; 2003 Dec; 278(52):52188-94. PubMed ID: 14551197
[TBL] [Abstract][Full Text] [Related]
55. Autoinhibition of Bcr-Abl through its SH3 domain.
Smith KM; Yacobi R; Van Etten RA
Mol Cell; 2003 Jul; 12(1):27-37. PubMed ID: 12887890
[TBL] [Abstract][Full Text] [Related]
56. Inactivation of wild-type BCR/ABL tyrosine kinase in hematopoietic cells by mild hyperthermia.
Jain SK; de Aos I; Inai Y; Liu F; Varticovski L
Leukemia; 2000 May; 14(5):845-52. PubMed ID: 10803516
[TBL] [Abstract][Full Text] [Related]
57. Solution structure of the human Hck SH3 domain and identification of its ligand binding site.
Horita DA; Baldisseri DM; Zhang W; Altieri AS; Smithgall TE; Gmeiner WH; Byrd RA
J Mol Biol; 1998 Apr; 278(1):253-65. PubMed ID: 9571048
[TBL] [Abstract][Full Text] [Related]
58. BCR sequences essential for transformation by the BCR-ABL oncogene bind to the ABL SH2 regulatory domain in a non-phosphotyrosine-dependent manner.
Pendergast AM; Muller AJ; Havlik MH; Maru Y; Witte ON
Cell; 1991 Jul; 66(1):161-71. PubMed ID: 1712671
[TBL] [Abstract][Full Text] [Related]
59. Tyrosine phosphorylation in the SH3 domain disrupts negative regulatory interactions within the c-Abl kinase core.
Chen S; O'Reilly LP; Smithgall TE; Engen JR
J Mol Biol; 2008 Nov; 383(2):414-23. PubMed ID: 18775435
[TBL] [Abstract][Full Text] [Related]
60. Crystal structure of the Src family kinase Hck SH3-SH2 linker regulatory region supports an SH3-dominant activation mechanism.
Alvarado JJ; Betts L; Moroco JA; Smithgall TE; Yeh JI
J Biol Chem; 2010 Nov; 285(46):35455-61. PubMed ID: 20810664
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
